-
201
-
202
Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature
Published 2023“…<p>Infection following SARS-Co V-2 leading to COVID-19 disease is associated with significant morbidity and mortality. The clinical entity, COVID-19 cytokine storm syndrome (CSS) is a severe immunological manifestation of the disease associated with ominous consequences. …”
-
203
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
Published 2020“…The use of poorly characterized MSC products remains one of the most significant drawbacks of MSC-based therapy, which could theoretically promote the risk for thromboembolism. …”
-
204
-
205
-
206
Quantitative MRI iron load assessment in β-thalassemia patients beyond the liver and heart: A systematic review
Published 2026“…MRI-derived iron load markers (T2*/R2*) showed significant correlations with endocrine, metabolic dysfunctions and systemic iron burden. …”
-
207
-
208
Direct Oral Anticoagulants Compared to Warfarin in Patients with Intermediate‐ to High‐Risk Pulmonary Embolism: A Systematic Review and Meta‐Analysis
Published 2025“…<h3>Introduction</h3><p dir="ltr">Despite recent advances in clinical therapeutics in patients with venous thromboembolism, uncertainty remains regarding the optimal anticoagulation strategy in patients with intermediate‐ to high‐risk pulmonary embolism. …”
-
209
-
210
-
211
Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data
Published 2020“…<p dir="ltr">According to publicly available transcriptome datasets, the abundance of Annexin A3 (ANXA3) is robustly increased during the course of sepsis; however, no studies have examined the biological significance or clinical relevance of ANXA3 in this pathology. …”
-
212
-
213
-
214
Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test
Published 2019“…Significantly, insulin and demographic features do not provide additional performance improvement for diabetes prediction. …”
-
215
-
216
-
217
-
218
Precision biomarker discovery in hypertension through explainable AI and proteomics
Published 2026“…<p dir="ltr">Hypertension is a major global health burden and a leading driver of cardiovascular disease, yet reliable blood-based biomarkers for early disease are still limited. …”
-
219
-
220